nucleoside

30 July 2025

A new target has been identified to prevent metastasis in breast cancer.

A study points to the TIM-3 protein as a key factor in breast cancer cells' ability to metastasize. This finding suggests a new therapeutic approach to prevent this process before it becomes clinically apparent.
22 July 2025

Aragonese researchers design nanoparticles that evolve in the tumor environment, generating two different therapies successively.

Experiments conducted by researchers from the University of Zaragoza affiliated with the INMA (CSIC-Unizar), IIS Aragón, and CIBER-BBN using cellular and animal models corroborate the efficacy of this combined chemodynamic and photothermal therapy.
August 12, 2024

The Hematology Research Group at HCU Lozano Blesa performs the first apheresis for CART therapy in Aragon

The IIS Aragón research group has been accredited for this process, the first part of these innovative therapies. CART therapy is increasingly being established as a treatment for hematological tumors, mainly lymphomas.
18 December, 2023

Aragón will apply advanced therapies in very aggressive cancers in children in four years

Aspanoa and the IIS Aragón organized an informative breakfast in Teruel last week with two Aragonese researchers to explain the latest advances in cancer research